Advertisement Details
15/10/2024Back
 Retatrutide Pharmaceutical Intermediate Cas 2381089-83-2 at Best Price

Retatrutide Pharmaceutical Intermediate Cas 2381089-83-2 at Best Price

guangzhou – Qingyuan – China, GuandongFacebook
Twitter
Industry > CHEMICALS, Acid, Powders, Discoveries, patents...
Source
Qingyuan.
65 Crossingssee all
Qingyuan (China, Guandong) - Miami (USA, East Coast)Qingyuan (China, Guandong) - Africa 4.0 (Continents)
Qingyuan (China, Guandong) - Singapore City (Singapore)Qingyuan (China, Guandong) - casablanca (Morocco)
Qingyuan (China, Guandong) - Shenzhen (China, Guandong)Qingyuan (China, Guandong) - Air (Coordinated transport)
Qingyuan (China, Guandong) - Madrid (Spain)Qingyuan (China, Guandong) - Manila (Philippines)
Qingyuan (China, Guandong) - Commonwealth (Economic Blocs)Qingyuan (China, Guandong) - San Jose (Costa Rica)
Qingyuan (China, Guandong) - Andean Community (American blocs)Qingyuan (China, Guandong) - Montevideo (Uruguay)
Qingyuan (China, Guandong) - ASEAN (Asian blocs)Qingyuan (China, Guandong) - GCC (Arabian blocs)
Qingyuan (China, Guandong) - New Delhi (India)Qingyuan (China, Guandong) - Havana (Cuba)
Qingyuan (China, Guandong) - Bogota (Colombia)Qingyuan (China, Guandong) - EAC (African blocs)
Qingyuan (China, Guandong) - Tel Aviv (Israel)Qingyuan (China, Guandong) - CEFTA (European blocs)
Qingyuan (China, Guandong) - Belt and Road 4.0 (Coordinated Routes)Qingyuan (China, Guandong) - Homemade (Energy ad hoc)
Qingyuan (China, Guandong) - Mexico city (Mexico)Qingyuan (China, Guandong) - Anping County (China, Bohai Bay)
Qingyuan (China, Guandong) - World 4.0 (All countries)Qingyuan (China, Guandong) - Industry 4.0 (China - Africa)
Description

Product Name: Retatrutide
CAS: 2381089-83-2
EINECS: 200-001-8
Mol File: Mol File
storage temp: -20°C
form: powder
color : White lyophilized
Water Solubility : Soluble in water (5mg/ml).

Trade
Alliance
Include thirds
Send message
Follow user
Multimedia files
 Retatrutide Pharmaceutical Intermediate Cas 2381089-83-2 at Best Price
Comments
New Comment
Submit